TY - JOUR
T1 - Muscle sympathetic nerve activity in patients with acromegaly
AU - Capaldo, Brunella
AU - Lembo, Giuseppe
AU - Rendina, Virgilio
AU - Guida, Raffaele
AU - Marzullo, Paolo
AU - Colao, Annamaria
AU - Lombardi, Gaetano
AU - Saccà, Luigi
PY - 2000
Y1 - 2000
N2 - Muscle sympathetic nerve activity was measured in nine acromegalic patients (age, 35 ± 4 yr; body mass index, 28 ± 2 kg/m2) and eight healthy subjects (age, 32 ± 3 yr; body mass index, 25 ± 2 kg/m2) by combining the forearm arterial-venous difference technique with the tracer method [infusion oftritiated norepinephrine (NE)]. Muscle NE release was quantified both at rest and during physiological hyperinsulinemia while maintaining euglycemia (~90 mg/dL) by means of the euglycemic clamp. Arterial plasma NE was similar in the two groups at rest (197 ± 28 and 200 ± 27 pg/mL-1) and slightly increased during insulin infusion. Forearm NE release was 2.33 ± 0.55 ng-liter-1·min-1 in healthy subjects and 2.67 ± 0.61 ng·liter-1·min-1 in acromegalic subjects in the basal state and increased to a similar extent during insulin infusion in both groups (3.13 ± 0.71 and 3.32 ± 0.75 ng·L-1. min-1, P < 0.05 vs. basal), indicating a normal stimulatory effect of insulin on muscle sympathetic activity. In contrast, insulin-stimulated forearm glucose uptake was markedly lower in acromegalic patients (2.3 ± 0.4 mg·L-1·min-1) than in control subjects (7.9 ± 1.3 mg·L-1·min-1, P < 0.001), indicating the presence of severe insulin resistance involving glucose metabolism. Our data demonstrate that patients with long-term acromegaly have normal sympathetic activity in the skeletal muscle in the basal, postabsorptive state and normal increments in NE spillover in response to the sympatho-excitatory effect of insulin. Thus, the presence of severe insulin resistance in acromegaly is not accounted for by adrenergic mechanisms.
AB - Muscle sympathetic nerve activity was measured in nine acromegalic patients (age, 35 ± 4 yr; body mass index, 28 ± 2 kg/m2) and eight healthy subjects (age, 32 ± 3 yr; body mass index, 25 ± 2 kg/m2) by combining the forearm arterial-venous difference technique with the tracer method [infusion oftritiated norepinephrine (NE)]. Muscle NE release was quantified both at rest and during physiological hyperinsulinemia while maintaining euglycemia (~90 mg/dL) by means of the euglycemic clamp. Arterial plasma NE was similar in the two groups at rest (197 ± 28 and 200 ± 27 pg/mL-1) and slightly increased during insulin infusion. Forearm NE release was 2.33 ± 0.55 ng-liter-1·min-1 in healthy subjects and 2.67 ± 0.61 ng·liter-1·min-1 in acromegalic subjects in the basal state and increased to a similar extent during insulin infusion in both groups (3.13 ± 0.71 and 3.32 ± 0.75 ng·L-1. min-1, P < 0.05 vs. basal), indicating a normal stimulatory effect of insulin on muscle sympathetic activity. In contrast, insulin-stimulated forearm glucose uptake was markedly lower in acromegalic patients (2.3 ± 0.4 mg·L-1·min-1) than in control subjects (7.9 ± 1.3 mg·L-1·min-1, P < 0.001), indicating the presence of severe insulin resistance involving glucose metabolism. Our data demonstrate that patients with long-term acromegaly have normal sympathetic activity in the skeletal muscle in the basal, postabsorptive state and normal increments in NE spillover in response to the sympatho-excitatory effect of insulin. Thus, the presence of severe insulin resistance in acromegaly is not accounted for by adrenergic mechanisms.
UR - http://www.scopus.com/inward/record.url?scp=0033710235&partnerID=8YFLogxK
U2 - 10.1210/jcem.85.9.6802
DO - 10.1210/jcem.85.9.6802
M3 - Article
SN - 0021-972X
VL - 85
SP - 3203
EP - 3207
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
IS - 9
ER -